A novel biphenotypic B-cell precursor leukemia cell line (NALM-29) carrying t(9;22)(q34;q11) established from a patient with acute leukemia

Leukemia Research

Volumn 23, Issue 8, 1999, Pages 731-740

  Matsuo, Yoshinobu ^a   Drexler, Hans G ^b   Takeuchi, Makoto ^c   Orita, Kunzo ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^b LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^c National Hospital Organization   (Japan)

Author keywords

ALL; Biphenotypic; Cell line; Leukemia; t(9; 22)

Indexed keywords

BCR ABL PROTEIN; CD19 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENTARY DNA; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; LYMPHOTOXIN; MICROSOMAL AMINOPEPTIDASE; MILODISTIM; MYELOPEROXIDASE; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; B CELL LEUKEMIA; BLAST CELL; CASE REPORT; CELL STRUCTURE; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 9; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; LEUKEMIA CELL LINE; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BASE SEQUENCE; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 9; DNA FINGERPRINTING; DNA PRIMERS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, PRE-B-CELL; MALE; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; RECEPTORS, CYTOKINE; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032810706     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00086-7     Document Type: Article

References (36)

1. First MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Cancer Genet Cytogenet 1986;23:189-97.
2. Second MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genet Cytogenet 1986;30:1-15.
3. Third MIC Cooperative Study Group. Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genet Cytogenet 1986;32:1-10.
4. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick J.R., Sultan C. Proposed revised criteria for the classification of the acute leukemias: A report of the French-American-British Cooperative Group. Ann. Intern. Med. 103:1985;620-625.
5. Wright S., Chucrallah A., Chong Y.Y., Kantarjian H., Keating M., Albitar M. Acute lymphoblastic leukemia with myeloperoxidase activity. Am. J. Hematol. 51:1996;147-151.
6. Zaki S.R., Austin G.E., Swan D., Srinivasan A., Ragab A.H., Chan W.C. Human myeloperoxidase gene expression in acute leukemia. Blood. 74:1989;2096-2102.
7. Yoneda N., Tatsumi E., Teshigawara K., Nagata S., Nagano T., Kishimoto Y., Kimura T., Yasunaga K., Yamaguchi N. Lineage determination of CD7+CD5- CD2- and CD7+CD5+CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3ε, and CD3δ Am. J. Hematol. 45:1994;310-320.
8. Zhou M., Findley H.W., Zaki S.R., Little F., Coffield L.M., Ragab A.H. Expression of myeloperoxidase mRNA by leukemic cells from childhood acute lymphoblastic leukemia. Leukemia. 7:1993;1180-1183.
9. Hu Z.-B., Ma W., Uphoff C.C., Metge K., Gignac S.M., Drexler H.G. Myeloperoxidase: expression and modulation in a large panel of human leukemia-lymphoma cell lines. Blood. 82:1993;1599-1607.
10. European Group for the Immunological Characterization of Leukemias, Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, Van't Veer MB.: proposals for the immunological classification of acute leukemias. Leukemia 1995;9:1783-6.
11. Matsuo Y. Drexler HG. Establishment and characterization of human B cell precursor-leukemia cell lines. Leu. Res. 22:1998;567-579.
12. Rosenfeld C., Gounter A., Choquet C., Venuat A.M., Kayibanda B., Pico J.L. Phenotypic characterization of a unique non-T, non-B acute lymphoblastic leukemia cell line. Nature. 267:1977;841-843.
13. Minowada J., Tsubota T., Greaves M.F., Walters T.R. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens. J. Natl. Cancer Inst. 59:1977;83-87.
14. Minowada J., Koshiba H., Janossy G., Greaves M.F., Bollum F.J. A Philadelphia chromosome positive human leukemia cell line (NALM-1) with pre-B characteristics. Leuk. Res. 3:1979;261-266.
15. Propp S., Lizzi F.A. Philadelphia chromosome in acute lymphocytic leukemia. Blood. 36:1970;353-360.
16. Okabe M., Matsushima S., Morioka M., Kobayashi M., Abe S., Sakurada K., Kakinuma M., Miyazaki T. Establishment and characterization of a cell line, TOM-1, derived from a patient with Philadelphia chromosome-positive acute lymphocytic leukemia. Blood. 69:1987;990-998.
17. Drexler H.G. Leukemia cell lines: in vitro models for the study of chronic myelocytic leukemia. Leuk. Res. 18:1994;919-927.
18. Homma T., Suzuki K., Kudo Y., Inagawa M., Mizuno S., Yamaguchi K., Tagawa M. Preparation and characterization of monoclonal antibodies against human myeloperoxidase. Arch. Biochem. Biophys. 273:1989;189-196.
19. Seabright M. A rapid banding technique for chromosomes. Lancet. 2:1971;971-972.
20. Hopert A., Uphoff C.C., Wirth M., Hauser H., Drexler H.G. Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines. J. Immunol. Methods. 164:1993;91-100.
21. Hane B., Tummler M., Jager K., Schleithoff L., Jansen J.W.G., Drexler H.G. Differences in DNA fingerprints of continuous leukemia-lymphoma cell lines from different sources. Leukemia. 6:1992;1129-1133.
22. Grande A., Manfredini R., Tagliafico E., Balestri R., Pizzanelli M., Papa S., Zucchini P., Bonsi L., Bagnara G., Torelli U., Ferrari S. All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells. Exp. Hematol. 23:1995;117-125.
23. Matsuo Y., MacLeod R.A.F., Kojima K., Kuwahara K., Sakata A., Drexler H.G., Nishizaki C., Fukuda S., Inoue Y., Sezaki T., Sakaguchi N., Orita K. A novel ALL-L3 cell line, BALM-16, lacking expression of immunoglobulin chains derived from a patient with hypercalcemia. Leukemia. 11:1997;2168-2174.
24. Johnson K.R., Nauseef W.M., Care A., Wheelock M.J., Shane S., Hudson S., Koeffler H.P., Selsted M., Miller C., Rovera G. Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence for multiple mRNA species. Nucl. Acid Res. 15:1987;2013-2028.
25. Kawasaki E.S., Clark S.S., Coyne M.Y., Smith S.D., Champlin R., Witte O.N., McCormick F.P. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc. Natl. Acad. Sci. USA. 85:1988;5698-5702.
26. Yamada M., Hudson S., Tournay O., Bittenbender S., Shane S.S., Lange B., Tsujimoto Y., Caton A.J., Rovera G. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc. Natl. Acad. Sci. USA. 86:1989;5123-5127.
27. Ohyashiki K., Fujieda H., Miyauchi J., Ohyashiki J.H., Tauchi T., Saito M., Nakazawa S., Abe K., Yamamoto K., Clark S.C., Toyama K. Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-3. Leukemia. 5:1991;322-331.
28. Matsuo Y., Adachi T., Tsubota T., Imanishi J., Minowada J. Establishment and characterization of a novel megakaryoblastic cell line, MOLM-1, from a patient with chronic myelogenous leukemia. Human Cell. 4:1991;261-264.
29. Ogawa S., Kurokawa M., Tanaka T., Mitani K., Inazawa J., Hangaishi A., Tanaka K., Matsuo Y., Minowada J., Tsubota T., Yazaki Y., Hirai H. Structurally altered Evi-1 protein generated in the 3q21q26 syndrome. Oncogene. 13:1996;183-191.
30. Pegoraro L., Matera L., Ritz J., Levis A., Palumbo A., Biagini G. Establishment of a Ph1-positive human cell line (BV-173). JNCI. 70:1983;447-453.
31. Matsuo Y., Ariyasu T., Ohmoto E., Kimura I., Minowada J. Biphenotypic t(9;22)-positive leukemia cell lines from a patient with acute leukemia: NALM-20, established at the onset; and NALM-21, NALM-22 and NALM-23, established after relapse. Human Cell. 4:1991;335-338.
32. Ariyasu T., Matsuo Y., Harashima A., Nakamura S., Takaba S., Tsubota T., Orita K. Establishment and characterization of 'biphenotypic' acute leukemia cell lines with a variant Ph translocation t(9;22;10)(q34;q11;q22). Human Cell. 11:1998;43-50.
33. Ferrari S., Mariano M.T., Tagliafico E., Sarti M., Ceccherelli G., Selleri L., Merli F., Marni F., Donelli A., Torelli U. Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in case of acute lymphoblastic leukemia. Blood. 72:1988;873-876.
34. Stass SA, Mirro J. Jr. Lineage heterogeneity in acute leukaemia: acute mixed lineage leukaemia and lineage switch. Clin Haematol 1986;15:811-27.
35. Matsuo Y., Sugimoto A., Kuwahara K., Watanabe Y., Sakata A., Sakaguchi N., Sagawa K., Orita K. Monoclonal antibody NU-B1 reacts with novel antigen on human B cells in mantle and marginal zones distinct from known CD molecules. Tissue Antigens. 52:1998;422-429.
36. Ohyashiki K., Miyauchi J., Ohyashiki J.H., Saito M., Yaguchi M., Inatomi Y., Nakazawa S., Wada H., Mizutani S., Matsuo Y., Minowada J., Toyama K. Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+acute lymphoblastic leukemia cell line OM9;22. Leukemia. 7:1993;1034-1040.